Company / Free Cash Flow
Integra Lifesciences Holdings Free Cash Flow History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Free Cash Flow
-$31.1M
FY2025
5-year range
-$31.1M / $264.4M
FY2021-FY2025
Trend
-224.4%
vs FY2024
Sector context
#129 of 151
Health Care
What the data says
Free Cash Flow changed -224% YoY in FY2025, a notable deviation from the 9-year average annual change of -17%.
Based on SEC 10-K filings.
-$31M in FY2025.
Declined from $73M to -$31M over the past 2 years.
Health Care sector context is included.
Free Cash Flow over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 15% in Health CareTop 85% of 151This company -$31.1M Sector average $779.8M
▼
-104.0% below sector average
Key checks
Key Insights
- Integra Lifesciences Holdings's free cash flow has declined for 4 consecutive years.
- In FY2025, free cash flow decreased 224.4% year-over-year.
- Ranks #129 out of 151 companies in the Health Care sector.
- Peak free cash flow was recorded in FY2021.
Company context
Key Data Points
- Altman Z-Score 0.44 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Free Cash FlowValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$31.1M | -224.4% |
| FY2024 | $25.0M | -65.8% |
| FY2023 | $73.1M | -67.1% |
| FY2022 | $222.1M | -16.0% |
| FY2021 | $264.4M | +60.3% |
| FY2020 | $164.9M | +1.9% |
| FY2019 | $161.9M | +32.8% |
| FY2018 | $121.9M | +70.7% |
| FY2017 | $71.4M | +58.0% |
| FY2016 | $45.2M | -36.7% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026